Neoadjuvant Chemoradiotherapy improves oncological results in resectable and borderline resectable Pancreatic Carcinomas, but not Overall Survival in resectable ones Results of the Dutch PREOPANC Study

被引：0
|
作者：
Hermann, Robert Michael [1 ]
Christiansen, Hans [2 ]
机构：
[1] Zentrum Strahlentherapie, Mozartstr 30, D-26655 Westerstede, Germany
[2] Hannover Med Sch, Klin Strahlentherapie & Spezielle Onkol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2021年 / 197卷 / 01期
关键词：
GEMCITABINE;
D O I：
10.1007/s00066-020-01717-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 88
页数：4
相关论文
共 50 条
  • [31] Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer
    Waugh, Evelyn
    Glinka, Juan
    Breadner, Daniel
    Liu, Rachel
    Tang, Ephraim
    Allen, Laura
    Welch, Stephen
    Leslie, Ken
    Skaro, Anton
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2024, 28 (02) : 229 - 237
  • [32] Total neoadjuvant therapy improves survival of patients with borderline resectable pancreatic cancer with arterial involvement
    Akahori, Takahiro
    Terai, Taichi
    Nagai, Minako
    Nakamura, Kota
    Kohara, Yuichiro
    Yasuda, Satoshi
    Matsuo, Yasuko
    Doi, Shunsuke
    Sakata, Takeshi
    Sho, Masayuki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024, 8 (01): : 151 - 162
  • [33] Total neoadjuvant FOLFIRINOX or gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2): A nationwide multicenter randomized controlled trial.
    Janssen, Quisette
    van Dam, Jacob L.
    Besselink, Marc G. H.
    Homs, Marjolein Y. V.
    van Tienhoven, Geertjan
    Wilmink, Johanna W.
    Koerkamp, Bas Groot
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy
    Shohei Takaichi
    Yoshito Tomimaru
    Shogo Kobayashi
    Keisuke Toya
    Kazuki Sasaki
    Yoshifumi Iwagami
    Daisaku Yamada
    Takehiro Noda
    Hidenori Takahashi
    Tadafumi Asaoka
    Masahiro Tanemura
    Yuichiro Doki
    Hidetoshi Eguchi
    Annals of Surgical Oncology, 2023, 30 : 2458 - 2468
  • [35] Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
    Q. P. Janssen
    J. L. van Dam
    B. A. Bonsing
    H. Bos
    K. P. Bosscha
    P. P. L. O. Coene
    C. H. J. van Eijck
    I. H. J. T. de Hingh
    T. M. Karsten
    M. B. van der Kolk
    G. A. Patijn
    M. S. L. Liem
    H. C. van Santvoort
    O. J. L. Loosveld
    J. de Vos-Geelen
    B. M. Zonderhuis
    M. Y. V. Homs
    G. van Tienhoven
    M. G. Besselink
    J. W. Wilmink
    B. Groot Koerkamp
    BMC Cancer, 21
  • [36] Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
    Janssen, Q. P.
    van Dam, J. L.
    Bonsing, B. A.
    Bos, H.
    Bosscha, K. P.
    Coene, P. P. L. O.
    van Eijck, C. H. J.
    de Hingh, I. H. J. T.
    Karsten, T. M.
    van der Kolk, M. B.
    Patijn, G. A.
    Liem, M. S. L.
    van Santvoort, H. C.
    Loosveld, O. J. L.
    De Vos-Geelen, J.
    Zonderhuis, B. M.
    Homs, M. Y., V
    van Tienhoven, G.
    Besselink, M. G.
    Wilmink, J. W.
    Koerkamp, B. Groot
    BMC CANCER, 2021, 21 (01)
  • [37] Borderline Resectable Pancreatic Cancer Patients Have Superior Survival Following Neoadjuvant Therapy Compared to Upfront Resectable Patients
    Deig, C.
    Trone, K.
    Beneville, B.
    Stratton, A.
    Liu, A.
    Kanwar, A.
    Grossblatt-Wait, A.
    Sheppard, B.
    Attia, F.
    Bassale, S.
    Chen, Y.
    Keith, D.
    Chen, E.
    Lopez, C.
    Gilbert, E.
    Billingsley, K.
    Nabavizadeh, N.
    Thomas, C. R., Jr.
    Grossberg, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E581 - E582
  • [38] Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.
    Van Tienhoven, Geertjan
    Versteijne, Eva
    Suker, Mustafa
    Groothuis, Karin B. C.
    Busch, Olivier R.
    Bonsing, Bert A.
    de Hingh, Ignace H. J. T.
    Festen, Sebastiaan
    Patijn, Gijs A.
    de Vos-Geelen, Judith
    Zwinderman, Aeilko H.
    Punt, Cornelis J. A.
    van Eijck, Casper H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18)
  • [39] Long-term survival of patients receiving multimodality neoadjuvant therapy for resectable or borderline resectable pancreatic ductal adenocarcinoma
    McCormick, Kinsey
    Whiting, Samuel H.
    Gyurkey, Grace
    Koh, Wui-Jin
    Sinanan, Mika
    Coveler, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [40] MZB1 in borderline resectable pancreatic cancer resected after neoadjuvant chemoradiotherapy
    Miyake, Kentaro
    Mori, Ryutaro
    Homma, Yuki
    Matsuyama, Ryusei
    Okayama, Akiko
    Murakami, Takashi
    Hirano, Hisashi
    Endo, Itaru
    JOURNAL OF SURGICAL RESEARCH, 2017, 220 : 391 - 401
12345